Ultragenyx Pharmaceutical (RARE) Q4 2021 Earnings

2NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-2.03
-1.48
-0.92
-0.37

Details

Expected EPS
-1.43
Actual EPS
-1.08
Surprise EPS
0.35
Surprise Percent
+24.48%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.08 per share for Q4 2021.

0 Comments

Share your thoughts